Clinical trials of conjunctive anticoagulant strategies in thrombolysis.
Baylor College of Medicine, Texas Medical Center, Houston 77030, USA.
N S
NS
Kleiman
D000925:Anticoagulants / Q000627:therapeutic use*; D000991:Antithrombins / Q000627:therapeutic use; D001120:Arginine / Q000031:analogs & derivatives; D001792:Blood Platelets / Q000502:physiology; D002986:Clinical Trials as Topic; D011464:Epoprostenol / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D024764:Hirudin Therapy; D006629:Hirudins / Q000031:analogs & derivatives; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D009842:Oligopeptides / Q000627:therapeutic use; D010446:Peptide Fragments / Q000627:therapeutic use; D010875:Pipecolic Acids / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors* / Q000502:physiology; D015912:Thrombolytic Therapy
D000925:Anticoagulants; D000991:Antithrombins; D006629:Hirudins; D009842:Oligopeptides; D010446:Peptide Fragments; D010875:Pipecolic Acids; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; D011464:Epoprostenol; D013917:Thrombin; C031942:argatroban; C074619:bivalirudin; C064289:efegatran